Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Immunogenicity and protective efficacy of a dual subunit vaccine against respiratory syncytial virus and influenza virus.

Park MH, Chang J.

Immune Netw. 2012 Dec;12(6):261-8. doi: 10.4110/in.2012.12.6.261. Epub 2012 Dec 31.

PMID:
23396871
[PubMed]
Free PMC Article
2.

Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.

Kim S, Jang JE, Yu JR, Chang J.

Vaccine. 2010 May 14;28(22):3801-8. doi: 10.1016/j.vaccine.2010.03.032. Epub 2010 Mar 31.

PMID:
20362203
[PubMed - indexed for MEDLINE]
3.

Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.

Mok H, Lee S, Utley TJ, Shepherd BE, Polosukhin VV, Collier ML, Davis NL, Johnston RE, Crowe JE Jr.

J Virol. 2007 Dec;81(24):13710-22. Epub 2007 Oct 10.

PMID:
17928349
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Dual role of respiratory syncytial virus glycoprotein fragment as a mucosal immunogen and chemotactic adjuvant.

Kim S, Joo DH, Lee JB, Shim BS, Cheon IS, Jang JE, Song HH, Kim KH, Song MK, Chang J.

PLoS One. 2012;7(2):e32226. doi: 10.1371/journal.pone.0032226. Epub 2012 Feb 27.

PMID:
22384186
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.

Power UF, Plotnicky-Gilquin H, Huss T, Robert A, Trudel M, Ståhl S, Uhlén M, Nguyen TN, Binz H.

Virology. 1997 Apr 14;230(2):155-66.

PMID:
9143271
[PubMed - indexed for MEDLINE]
Free Article
6.

Complete protection of mice from respiratory syncytial virus infection following mucosal delivery of synthetic peptide vaccines.

Bastien N, Trudel M, Simard C.

Vaccine. 1999 Feb 26;17(7-8):832-6.

PMID:
10067688
[PubMed - indexed for MEDLINE]
7.

Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.

Fu Y, He J, Zheng X, Wu Q, Zhang M, Wang X, Wang Y, Xie C, Tang Q, Wei W, Wang M, Song J, Qu J, Zhang Y, Wang X, Hong T.

Biochem Biophys Res Commun. 2009 Apr 17;381(4):528-32. doi: 10.1016/j.bbrc.2009.02.075. Epub 2009 Feb 20.

PMID:
19233131
[PubMed - indexed for MEDLINE]
8.
9.

Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity.

Cusi MG, Zurbriggen R, Correale P, Valassina M, Terrosi C, Pergola L, Valensin PE, Glück R.

Vaccine. 2002 Oct 4;20(29-30):3436-42.

PMID:
12297388
[PubMed - indexed for MEDLINE]
10.

Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.

Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.

Virology. 2008 Oct 25;380(2):412-20. doi: 10.1016/j.virol.2008.08.002. Epub 2008 Sep 10.

PMID:
18786689
[PubMed - indexed for MEDLINE]
Free Article
11.
12.

Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.

Huang Y, Cyr SL, Burt DS, Anderson R.

J Clin Virol. 2009 Apr;44(4):287-91. doi: 10.1016/j.jcv.2009.01.009. Epub 2009 Feb 23.

PMID:
19233722
[PubMed - indexed for MEDLINE]
13.

Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.

Cavanagh D.

Avian Pathol. 2003 Dec;32(6):567-82. Review.

PMID:
14676007
[PubMed - indexed for MEDLINE]
14.

Development of safe and effective RSV Vaccine by modified CD4 epitope in G protein core fragment (Gcf).

Cheon IS, Shim BS, Park SM, Choi Y, Jang JE, Jung DI, Kim JO, Chang J, Yun CH, Song MK.

PLoS One. 2014 Apr 15;9(4):e94269. doi: 10.1371/journal.pone.0094269. eCollection 2014.

PMID:
24736750
[PubMed - in process]
Free PMC Article
15.

Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection.

Yu JR, Kim S, Lee JB, Chang J.

J Virol. 2008 Mar;82(5):2350-7. Epub 2007 Dec 19.

PMID:
18094185
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B.

Power UF, Plotnicky H, Blaecke A, Nguyen TN.

Vaccine. 2003 Dec 12;22(2):168-76.

PMID:
14615143
[PubMed - indexed for MEDLINE]
17.

Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.

Tebbey PW, Scheuer CA, Peek JA, Zhu D, LaPierre NA, Green BA, Phillips ED, Ibraghimov AR, Eldridge JH, Hancock GE.

Vaccine. 2000 Jun 1;18(24):2723-34.

PMID:
10781860
[PubMed - indexed for MEDLINE]
18.

Mucosal immunization with a subunit respiratory syncytial virus vaccine in mice.

Walsh EE.

Vaccine. 1993;11(11):1135-8.

PMID:
8249433
[PubMed - indexed for MEDLINE]
19.

Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit.

Tamura S, Samegai Y, Kurata H, Nagamine T, Aizawa C, Kurata T.

Vaccine. 1988 Oct;6(5):409-13.

PMID:
2848377
[PubMed - indexed for MEDLINE]
20.

Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice.

Bian C, Liu S, Liu N, Zhang G, Xing L, Song Y, Duan Y, Gu H, Zhou Y, Zhang P, Li Z, Zhang K, Wang Z, Zhang S, Wang X, Yang P.

Antiviral Res. 2014 Apr;104:110-7. doi: 10.1016/j.antiviral.2014.01.022. Epub 2014 Feb 6.

PMID:
24509239
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk